FDA Adverse Event Malfunction Summary report: N

DEXTRUS 4136

MDR report key: 2914120 · Received December 7, 2012

Report

Report Number
1028232-2012-03126
Event Type
Malfunction
Date Received
December 7, 2012
Date of Event
May 17, 2012
Report Date
November 23, 2012
Manufacturer
BIOTRONIK SE & CO. KG
Product Code
NVZ
PMA / PMN Number
P950037
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

UPON RECEIPT, THE LEAD WAS FOUND DISSECTED. ONLY THE PROXIMAL FRAGMENT WAS RECEIVED. THE FRAGMENTATION OF THE LEAD MOST LIKELY ORIGINATED FROM THE EXPLANTATION PROCEDURE. THE RETURNED DEVICE WAS VISUALLY AND ELECTRICALLY ANALYZED. THE INSPECTION OF THE INSULATION CONFIRMED THAT THE LEAD WAS, APART FROM THE PRESENT CUTTINGS, FREE OF INSULATION BREACHES. IN ADDITION, THE DC RESISTANCES OF THE CONDUCTOR FRAGMENTS WERE INVESTIGATED AND PROVED TO BE FLAWLESS. NO PECULIARITIES WERE FOUND. THE QUALITY DOCUMENTS ASSOCIATED WITH THE MANUFACTURE OF THIS PARTICULAR DEVICE WERE RE-INVESTIGATED. THERE WAS NO SIGN OF ANY INCONSISTENCY DURING PRODUCTION AND FINAL ACCEPTANCE TEST. IN SUMMARY, NO INDICATION OF A MATERIAL OR MANUFACTURING PROBLEM WAS NOTED DURING ANALYSIS.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFO THAT AT IMPLANT OF THIS RIGHT VENTRICULAR LEAD, HIGH THRESHOLD MEASUREMENTS WERE NOTED. ADDITIONALLY, IMPEDANCE MEASUREMENTS WERE WITHIN RANGE BUT ELEVATED AND SLIGHTLY HIGHER UTILIZING THE PACING SYSTEM ANALYZER. FOLLOWING IMPLANT, THRESHOLD MEASUREMENTS HAD INCREASED, IMPEDANCE COULD NOT BE MEASURED, NO CAPTURE WAS OBSERVED AND NO SENSING MEASUREMENTS COULD BE OBTAINED IN UNIPOLAR CONFIGURATION. THE PT HAS A PRESSURE DRESSING AND THERE IS SOME FLUID IN THE POCKET. NO ADVERSE PT EFFECTS WERE REPORTED. NO EXPLANT DATE WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 DEXTRUS 4136 PACER LEAD NVZ BIOTRONIK SE & CO. KG 358754

Patients

Seq Age Sex Outcome Treatment
1 UNK Hospitalization